1. Home
  2. PACB vs UAMY Comparison

PACB vs UAMY Comparison

Compare PACB & UAMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACB
  • UAMY
  • Stock Information
  • Founded
  • PACB 2000
  • UAMY 1968
  • Country
  • PACB United States
  • UAMY United States
  • Employees
  • PACB N/A
  • UAMY N/A
  • Industry
  • PACB Biotechnology: Laboratory Analytical Instruments
  • UAMY Metal Fabrications
  • Sector
  • PACB Industrials
  • UAMY Industrials
  • Exchange
  • PACB Nasdaq
  • UAMY Nasdaq
  • Market Cap
  • PACB 364.2M
  • UAMY 316.8M
  • IPO Year
  • PACB 2010
  • UAMY N/A
  • Fundamental
  • Price
  • PACB $1.37
  • UAMY $3.90
  • Analyst Decision
  • PACB Buy
  • UAMY Strong Buy
  • Analyst Count
  • PACB 9
  • UAMY 4
  • Target Price
  • PACB $2.06
  • UAMY $3.38
  • AVG Volume (30 Days)
  • PACB 9.3M
  • UAMY 6.8M
  • Earning Date
  • PACB 08-06-2025
  • UAMY 08-08-2025
  • Dividend Yield
  • PACB N/A
  • UAMY N/A
  • EPS Growth
  • PACB N/A
  • UAMY N/A
  • EPS
  • PACB N/A
  • UAMY N/A
  • Revenue
  • PACB $152,357,000.00
  • UAMY $18,865,900.00
  • Revenue This Year
  • PACB $3.33
  • UAMY $270.45
  • Revenue Next Year
  • PACB $17.88
  • UAMY $104.06
  • P/E Ratio
  • PACB N/A
  • UAMY N/A
  • Revenue Growth
  • PACB N/A
  • UAMY 97.46
  • 52 Week Low
  • PACB $0.85
  • UAMY $0.30
  • 52 Week High
  • PACB $2.72
  • UAMY $4.19
  • Technical
  • Relative Strength Index (RSI)
  • PACB 52.51
  • UAMY 76.51
  • Support Level
  • PACB $1.36
  • UAMY $2.71
  • Resistance Level
  • PACB $1.62
  • UAMY $2.33
  • Average True Range (ATR)
  • PACB 0.11
  • UAMY 0.30
  • MACD
  • PACB -0.01
  • UAMY 0.20
  • Stochastic Oscillator
  • PACB 41.98
  • UAMY 94.31

About PACB Pacific Biosciences of California Inc.

Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.

About UAMY United States Antimony Corporation

United States Antimony Corp is a fully integrated mining, transportation, milling, smelting, and selling company. It has two operating segments: antimony and zeolite. Its products and services include antimony; silver; gold; zeolite products; and storage, handling, & packaging services. The company's geographical segments are the United States, Canada, and Mexico, of which the vast majority of its revenue comes from the United States.

Share on Social Networks: